JMP Securities Upgrades Allergan to “Outperform” (AGN)

JMP Securities reported that they have upgraded health care company, Allergan, Inc.(AGN) on Wednesday.

The firm has raised their rating on AGN from “Market Perform” to “Outperform,” and has given the company a $135 price target. This price target suggests a 20% increase from the stock’s current price of $108.12.

Analysts have upgraded the company due to a higher demand for Botox.

Allergan shares were up $1.42, or 1.33% during Wednesday morning trading. The stock has increased 25% in the past year.

The Bottom Line
Shares of Allergan, Inc.(AGN) have a 0.18% yield, based on Wednesday morning’s price of $108.12.

Allergan, Inc.(AGN) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here